Rich has been a leader of change for over 25 years, working with some of the world’s most innovative companies – such as GlaxoSmithKline and TetraLaval. Career highlights include CEO of a multi-national, NED of a publicly listed company, and now Principal of the High Performance Change practice. On the way, he worked the night-shift on a packing line, led a 3-year supplier restructuring programme, and ran a $1b global supply chain. Having witnessed first-hand that projects only tend to change what people do, rather than how they feel about change itself, Rich developed the High Performance Change programme to focus on helping people become more adaptable.
Rich is a highly experienced keynote speaker, blending his thought-leading ideas on culture and strategy with a challenging and humorous style which audiences find both highly relevant and entertaining. He also provides executive mentoring. Having walked a mile in the shoes of those he works with, he can draw on his own successes and failures to help them become the people they want to be, and the leaders their organisations need them to be.
Above all, Rich is driven to help others become more adaptable so they can enjoy rather than endure a life of change that surely lies ahead for everyone.
About High Performance Change
In an increasingly dynamic world, adaptability is the one core skill to rule them all. Ultimately, it doesn’t matter how good people are as e.g. marketers, or engineers, or lawyers, unless they can also adapt to how the game is being played. Change isn’t just a process to be managed one project at a time, it’s a form of intelligence that can be developed and applied – just like intelligence in maths, or music, or martial arts.
The High Performance Change model identifies 6 levels of change intelligence, from the ‘fear of change’ to the ‘freedom to change’. At each level, practical antidotes are provided to deal with the reasons people resist change, as well as stimulants to help catalyse their journey towards mastering adaptability. It has changed the way people live their lives – both inside and outside work – by giving them the courage to become adaptable.
Inclusion, organizational effectiveness, behavioral science expert consultant.
For over 20 years, Amri Johnson has been instrumental in helping organizations and their people create extraordinary business outcomes. He is a social capitalist, epidemiologist, entrepreneur, executive coach, and inclusion strategist. Amri’s dialogic approach to engaging all people as leaders and change agents (most recently at the research division of Novartis, as Global Head of Cultural Intelligence and Inclusion) has fostered the opening of minds and deepening of skillsets with organizational leaders and citizens enabling them to thrive and optimally contribute to one another and their respective organizations.
Amri is currently writing a manuscript for change makers with the intention of systemically embedding inclusion in a manner that is accessible (for all), actionable (in daily business practice), and sustainable (organizationally normative).
Born in Topeka, Kansas (USA), Amri has worked and lived in the U.S., Brazil, and currently lives in Basel, Switzerland, with his wife Martina and their three children.
N-Site is a portal for Life Sciences companies with a range of technical guidance notes and workshops on tax, legal, patent & trademark, insurance, M&A and executive search matters that impact the industry.
Established by FTI Consulting and developed in association with MedCity and the BioIndustry Association (BIA), the vision is that N-Site will become a primary resource for Expert Guidance for Life Sciences.
The aim of N-Site is simple: to be the primary hub of expert guidance for UK based Life Sciences companies – from embryonic start-ups to established multinationals.
Optimizing commercial readiness of rare disease and gene and cell therapies for early-stage biotech companies (US and global)
Operating as an independent yet integrated extension of your organization, RCP is dedicated to accelerating commercial readiness.
Engaging a team of senior commercial leaders with comprehensive biotech experience and unparalleled proficiency in critical subject matter areas essential to support strategic commercialization, increased valuation and launch success – including market assessments, positioning and messages, brand planning, patient and market access, key investigator planning and patient identification, and change management.
RCP offers a foundational shift in how biotech companies can achieve rapid time to value.